Marouni Mehran J, Barzilai Asher, Keller N, Rubinstein Eitan, Sela Shlomo
Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Int J Med Microbiol. 2004 Jul;294(1):27-33. doi: 10.1016/j.ijmm.2004.01.001.
Group A streptococcus (GAS) is the principle etiologic agent of bacterial pharyngotonsillitis and a wide range of other diseases. Failure to eradicate GAS from patients has been documented in 5-30% of patients with pharyngotonsillitis, in spite of the continued sensitivity of GAS to penicillin and other beta-lactams. It was recently proposed that eradication failure might be attributed to the ability of GAS to maintain an intracellular reservoir during antibiotic treatment. We have previously shown that strains derived from patients with bacterial eradication failure, despite antibiotic treatment (persistent strains), adhered to and were internalized by cultured epithelial cells more efficiently than strains that were successfully eradicated. Since, penicillin and other beta-lactams do not penetrate well into mammalian cells, intracellular survival of GAS is crucial in order to persist during prolonged antibiotic treatment. In this study, we compared the survival of GAS strains from cases of eradication failure and eradication success, using an epithelial cell culture model. We found that persistent strains show significantly increased intracellular survival, compared to the 'eradication success' strains. This finding supports the idea that an intracellular reservoir of GAS plays a role in the etiology of antibiotic eradication failure.
A组链球菌(GAS)是细菌性咽扁桃体炎及多种其他疾病的主要病原体。尽管GAS对青霉素和其他β-内酰胺类药物仍敏感,但在5%-30%的咽扁桃体炎患者中,已证实存在未能从患者体内根除GAS的情况。最近有人提出,根除失败可能归因于GAS在抗生素治疗期间维持细胞内储存库的能力。我们之前已经表明,尽管接受了抗生素治疗,但来自细菌根除失败患者的菌株(持续菌株)比成功根除的菌株更有效地黏附并被培养的上皮细胞内化。由于青霉素和其他β-内酰胺类药物不能很好地穿透哺乳动物细胞,GAS在细胞内的存活对于在长期抗生素治疗期间持续存在至关重要。在本研究中,我们使用上皮细胞培养模型比较了根除失败和根除成功病例中GAS菌株的存活情况。我们发现,与“根除成功”菌株相比,持续菌株的细胞内存活率显著提高。这一发现支持了GAS的细胞内储存库在抗生素根除失败病因中起作用的观点。